Ranbaxy is India's largest pharmaceutical company with a global presence in 46 countries. It has a mission to become a research-based international pharmaceutical company. Ranbaxy has over 1,400 R&D personnel and is the highest R&D spender in the industry. It focuses on increasing momentum in generics through organic and inorganic growth. Ranbaxy's top products include Simvastatin for cholesterol and Amoxicillin/Clavulanate potassium for bacterial infections. It is currently the second largest player in the Indian market and achieved sales of $1.5 billion globally in 2009.